A new role for STAT3 as a regulator of chromatin topology
暂无分享,去创建一个
Yunjie Zhao | Anatoly Dritschilo | Yunjie Zhao | S. Chasovskikh | A. Dritschilo | N. Tarasova | Nadya I Tarasova | O. Timofeeva | Chen Zeng | Sergey Chasovskikh | Olga A Timofeeva | C. Zeng
[1] B. Chait,et al. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2‐terminal domains stabilizes binding of two dimers to tandem DNA sites. , 1996, The EMBO journal.
[2] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[3] H. Land,et al. Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth , 2013, Proceedings of the National Academy of Sciences.
[4] S. Lim,et al. Drosophila STAT is required for directly maintaining HP1 localization and heterochromatin stability , 2008, Nature Cell Biology.
[5] V. Theodorou,et al. Estrogen receptor action in three dimensions - looping the loop , 2010, Breast Cancer Research.
[6] Yangyu Huang,et al. Automated and fast building of three-dimensional RNA structures , 2012, Scientific Reports.
[7] Giacomo Cavalli,et al. Genomic interactions: chromatin loops and gene meeting points in transcriptional regulation. , 2009, Seminars in cell & developmental biology.
[8] Cameron S. Osborne,et al. Active genes dynamically colocalize to shared sites of ongoing transcription , 2004, Nature Genetics.
[9] J. Darnell,et al. The JAK-STAT pathway at twenty. , 2012, Immunity.
[10] Peter Fraser,et al. The role of transcription factories in large-scale structure and dynamics of interphase chromatin. , 2007, Seminars in cell & developmental biology.
[11] Steven M Holland,et al. JAKs and STATs in immunity, immunodeficiency, and cancer. , 2013, The New England journal of medicine.
[12] D. Levy,et al. IL-6 signaling via the STAT3/SOCS3 pathway: Functional Analysis of the Conserved STAT3 N-domain , 2006, Molecular and Cellular Biochemistry.
[13] A. Cheema,et al. STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain , 2013, Proceedings of the National Academy of Sciences.
[14] Yangyu Huang,et al. A novel protocol for three-dimensional structure prediction of RNA-protein complexes , 2013, Scientific Reports.
[15] G. Stark,et al. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.
[16] Peter Fraser,et al. Gene regulation through nuclear organization , 2007, Nature Structural &Molecular Biology.
[17] David N Arnosti,et al. Transcriptional enhancers: Intelligent enhanceosomes or flexible billboards? , 2005, Journal of cellular biochemistry.
[18] Bernd Groner,et al. TRANSCRIPTION FACTOR STAT3B/DNA COMPLEX , 1999 .
[19] Kairong Cui,et al. Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. , 2012, Immunity.
[20] Willis X. Li,et al. JAK signaling globally counteracts heterochromatic gene silencing , 2006, Nature Genetics.
[21] S. Becker,et al. Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.
[22] J. Darnell,et al. The Significance of Tetramerization in Promoter Recruitment by Stat5 , 1999, Molecular and Cellular Biology.
[23] I. Mills,et al. Chromatin binding by the androgen receptor in prostate cancer , 2012, Molecular and Cellular Endocrinology.
[24] Mark A. Rubin,et al. Oncogenic transcription factors as master regulators of chromatin topology , 2012, Cell cycle.
[25] J. Farrar,et al. Role of the Stat4 N Domain in Receptor Proximal Tyrosine Phosphorylation , 2000, Molecular and Cellular Biology.
[26] E. Cheung,et al. Estrogen receptor-mediated long-range chromatin interactions and transcription in breast cancer , 2014, Molecular and Cellular Endocrinology.
[27] Valeriy R. Korostyshevskiy,et al. Mechanisms of Unphosphorylated STAT3 Transcription Factor Binding to DNA* , 2012, The Journal of Biological Chemistry.
[28] M. Sung,et al. Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation , 2013, Genome research.
[29] S. Lockett,et al. Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target. , 2007, ACS chemical biology.
[30] N. Tarasova,et al. Alternative ways of modulating JAK-STAT pathway , 2012, JAK-STAT.
[31] J. Darnell,et al. Structure of the amino-terminal protein interaction domain of STAT-4. , 1998, Science.
[32] J. Darnell,et al. Functional Importance of Stat3 Tetramerization in Activation of the α2-Macroglobulin Gene* , 2001, The Journal of Biological Chemistry.
[33] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[34] N. D. Clarke,et al. Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.